| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9237805 | Digestive and Liver Disease | 2005 | 7 Pages |
Abstract
As yet, early use of biological agents remains to be supported by convincing evidence, nevertheless it may be advocated as first-line therapy for newly diagnosed severe Crohn's disease patients, both adults and children.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
R. Caprilli, E. Angelucci, A. Cocco,